BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kotanko P, Carter M, Levin NW. Intestinal bacterial microflora--a potential source of chronic inflammation in patients with chronic kidney disease. Nephrol Dial Transplant. 2006;21:2057-2060. [PMID: 16762961 DOI: 10.1093/ndt/gfl281] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Kato S, Lindholm B, Stenvinkel P, Ekström TJ, Luttropp K, Yuzawa Y, Yasuda Y, Tsuruta Y, Maruyama S. DNA hypermethylation and inflammatory markers in incident Japanese dialysis patients. Nephron Extra 2012;2:159-68. [PMID: 22811689 DOI: 10.1159/000339437] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
2 Reyes-Bahamonde J, Raimann JG, Thijssen S, Levin NW, Kotanko P. Fluid overload and inflammation--a vicious cycle. Semin Dial 2013;26:31-5. [PMID: 23043638 DOI: 10.1111/sdi.12024] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
3 Cornelis T, Kotanko P, Goffin E, Kooman JP, van der Sande FM, Chan CT. Can Intensive Hemodialysis Prevent Loss of Functionality in the Elderly ESRD Patient?: INTENSIVE HD IN THE ELDERLY ESRD PATIENT. Seminars in Dialysis 2011;24:645-52. [DOI: 10.1111/j.1525-139x.2011.00995.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
4 Li M, Zhang S, Qiu Y, He Y, Chen B, Mao R, Cui Y, Zeng Z, Chen M. Upregulation of miR-665 promotes apoptosis and colitis in inflammatory bowel disease by repressing the endoplasmic reticulum stress components XBP1 and ORMDL3. Cell Death Dis 2017;8:e2699. [PMID: 28333149 DOI: 10.1038/cddis.2017.76] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 8.6] [Reference Citation Analysis]
5 Cruz-mora J, Martínez-hernández NE, Martín del Campo-lópez F, Viramontes-hörner D, Vizmanos-lamotte B, Muñoz-valle JF, García-garcía G, Parra-rojas I, Castro-alarcón N. Effects of a Symbiotic on Gut Microbiota in Mexican Patients With End-Stage Renal Disease. Journal of Renal Nutrition 2014;24:330-5. [DOI: 10.1053/j.jrn.2014.05.006] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]
6 Hsu CC, Wei TS, Huang CC, Chen YM. Endotoxemia is associated with acute coronary syndrome in patients with end stage kidney disease. BMC Nephrol 2017;18:235. [PMID: 28701158 DOI: 10.1186/s12882-017-0652-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
7 Yong-hui Li, Li P, Tan Y, Cai H, Zhang X, Li Y, Zhang J. Comparative Pharmacokinetics of Nootkatone in a RAT Model of Chronic Kidney Disease VERSUS Normal Controls. J Anal Chem 2019;74:722-7. [DOI: 10.1134/s1061934819070050] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Finkelstein FO, Juergensen P, Wang S, Santacroce S, Levine M, Kotanko P, Levin NW, Handelman GJ. Hemoglobin and plasma vitamin C levels in patients on peritoneal dialysis. Perit Dial Int 2011;31:74-9. [PMID: 20558814 DOI: 10.3747/pdi.2009.00154] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
9 Kotanko P. Chronic inflammation in dialysis patients - periodontal disease, the new kid on the block: Commentary. Oral Diseases 2008;14:8-9. [DOI: 10.1111/j.1601-0825.2007.01431.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
10 Crowley LE, Mcintyre CW. Remote ischaemic conditioning—therapeutic opportunities in renal medicine. Nat Rev Nephrol 2013;9:739-46. [DOI: 10.1038/nrneph.2013.226] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
11 Lemesch S, Ribitsch W, Schilcher G, Spindelböck W, Hafner-Gießauf H, Marsche G, Pasterk L, Payerl D, Schmerböck B, Tawdrous M, Rosenkranz AR, Stiegler P, Kager G, Hallström S, Oettl K, Eberhard K, Horvath A, Leber B, Stadlbauer V. Mode of renal replacement therapy determines endotoxemia and neutrophil dysfunction in chronic kidney disease. Sci Rep 2016;6:34534. [PMID: 27698480 DOI: 10.1038/srep34534] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
12 Wang IK, Lai HC, Yu CJ, Liang CC, Chang CT, Kuo HL, Yang YF, Lin CC, Lin HH, Liu YL. Real-time PCR analysis of the intestinal microbiotas in peritoneal dialysis patients. Appl Environ Microbiol. 2012;78:1107-1112. [PMID: 22179250 DOI: 10.1128/aem.05605-11] [Cited by in Crossref: 48] [Cited by in F6Publishing: 32] [Article Influence: 4.4] [Reference Citation Analysis]
13 Zirker L. Probiotic Use in Chronic Kidney Disease Patients. Journal of Renal Nutrition 2014;24:e47-9. [DOI: 10.1053/j.jrn.2014.08.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
14 Meijers B, Jouret F, Evenepoel P. Linking gut microbiota to cardiovascular disease and hypertension: Lessons from chronic kidney disease. Pharmacological Research 2018;133:101-7. [DOI: 10.1016/j.phrs.2018.04.023] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 6.5] [Reference Citation Analysis]
15 Lee YJ, Li KY, Wang PJ, Huang HW, Chen MJ. Alleviating chronic kidney disease progression through modulating the critical genus of gut microbiota in a cisplatin-induced Lanyu pig model. J Food Drug Anal 2020;28:103-14. [PMID: 31883598 DOI: 10.1016/j.jfda.2019.10.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
16 Sun PP, Perianayagam MC, Jaber BL. Endotoxin-binding affinity of sevelamer: a potential novel anti-inflammatory mechanism. Kidney Int Suppl 2009;:S20-5. [PMID: 19946323 DOI: 10.1038/ki.2009.403] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
17 Di Iorio BR, Rocchetti MT, De Angelis M, Cosola C, Marzocco S, Di Micco L, di Bari I, Accetturo M, Vacca M, Gobbetti M, Di Iorio M, Bellasi A, Gesualdo L. Nutritional Therapy Modulates Intestinal Microbiota and Reduces Serum Levels of Total and Free Indoxyl Sulfate and P-Cresyl Sulfate in Chronic Kidney Disease (Medika Study). J Clin Med 2019;8:E1424. [PMID: 31510015 DOI: 10.3390/jcm8091424] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 11.3] [Reference Citation Analysis]
18 Martins AR, Branco P, Gaspar A. Lactobacillus casei Peritonitis in Peritoneal Dialysis: A Rare Case and Literature Review. Ther Apher Dial 2016;20:90-2. [DOI: 10.1111/1744-9987.12375] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Shi K, Wang F, Jiang H, Liu H, Wei M, Wang Z, Xie L. Gut bacterial translocation may aggravate microinflammation in hemodialysis patients. Dig Dis Sci. 2014;59:2109-2117. [PMID: 24828917 DOI: 10.1007/s10620-014-3202-7] [Cited by in Crossref: 91] [Cited by in F6Publishing: 85] [Article Influence: 11.4] [Reference Citation Analysis]
20 Wang IK, Wu YY, Yang YF, Ting IW, Lin CC, Yen TH, Chen JH, Wang CH, Huang CC, Lin HC. The effect of probiotics on serum levels of cytokine and endotoxin in peritoneal dialysis patients: a randomised, double-blind, placebo-controlled trial. Benef Microbes 2015;6:423-30. [PMID: 25609654 DOI: 10.3920/BM2014.0088] [Cited by in Crossref: 82] [Cited by in F6Publishing: 33] [Article Influence: 11.7] [Reference Citation Analysis]
21 Sun PP, Perianayagam MC, Jaber BL. Sevelamer hydrochloride use and circulating endotoxin in hemodialysis patients: a pilot cross-sectional study. J Ren Nutr 2009;19:432-8. [PMID: 19464926 DOI: 10.1053/j.jrn.2009.01.022] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
22 Sirover WD, Liu Y, Logan A, Hunter K, Benz RL, Prasad D, Avila J, Venkatchalam T, Weisberg LS, Handelman GJ. Plasma ascorbic acid concentrations in prevalent patients with end-stage renal disease on hemodialysis. J Ren Nutr 2015;25:292-300. [PMID: 25455040 DOI: 10.1053/j.jrn.2014.09.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
23 Tang Y, Saris PE. Strain-specific detection of orally administered canine jejunum-dominated Lactobacillus acidophilus LAB20 in dog faeces by real-time PCR targeted to the novel surface layer protein. Lett Appl Microbiol 2013;57:330-5. [PMID: 23758090 DOI: 10.1111/lam.12117] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
24 Chen Y, Biada J, Sood S, Rabkin R. Uremia attenuates growth hormone-stimulated insulin-like growth factor-1 expression, a process worsened by inflammation. Kidney Int. 2010;78:89-95. [PMID: 20375991 DOI: 10.1038/ki.2010.85] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
25 Lukaszyk E, Lukaszyk M, Koc-Zorawska E, Bodzenta-Lukaszyk A, Malyszko J. Zonulin, inflammation and iron status in patients with early stages of chronic kidney disease. Int Urol Nephrol 2018;50:121-5. [PMID: 29134616 DOI: 10.1007/s11255-017-1741-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
26 Leitner GC, Vogelsang H. Pharmacological- and non-pharmacological therapeutic approaches in inflammatory bowel disease in adults. World J Gastrointest Pharmacol Ther 2016; 7(1): 5-20 [PMID: 26855808 DOI: 10.4292/wjgpt.v7.i1.5] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 23] [Article Influence: 4.5] [Reference Citation Analysis]
27 Harrison LE, Burton JO, Szeto CC, Li PK, McIntyre CW. Endotoxaemia in haemodialysis: a novel factor in erythropoetin resistance? PLoS One 2012;7:e40209. [PMID: 22768256 DOI: 10.1371/journal.pone.0040209] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
28 Crespo-Salgado J, Vehaskari VM, Stewart T, Ferris M, Zhang Q, Wang G, Blanchard EE, Taylor CM, Kallash M, Greenbaum LA, Aviles DH. Intestinal microbiota in pediatric patients with end stage renal disease: a Midwest Pediatric Nephrology Consortium study. Microbiome 2016;4:50. [PMID: 27640125 DOI: 10.1186/s40168-016-0195-9] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 5.2] [Reference Citation Analysis]
29 Aw W, Fukuda S. The Role of Integrated Omics in Elucidating the Gut Microbiota Health Potentials. In: Liong M, editor. Beneficial Microorganisms in Medical and Health Applications. Cham: Springer International Publishing; 2015. pp. 73-100. [DOI: 10.1007/978-3-319-23213-3_4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
30 Wei M, Wang Z, Liu H, Jiang H, Wang M, Liang S, Shi K, Feng J. Probiotic Bifidobacterium animalis subsp. lactis Bi-07 alleviates bacterial translocation and ameliorates microinflammation in experimental uraemia: Beneficial effect of probiotic on uraemia. Nephrology 2014;19:500-6. [DOI: 10.1111/nep.12272] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
31 Vitetta L, Gobe G. Uremia and chronic kidney disease: the role of the gut microflora and therapies with pro- and prebiotics. Mol Nutr Food Res 2013;57:824-32. [PMID: 23450842 DOI: 10.1002/mnfr.201200714] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 4.9] [Reference Citation Analysis]
32 Wang IK, Yen TH, Hsieh PS, Ho HH, Kuo YW, Huang YY, Kuo YL, Li CY, Lin HC, Wang JY. Effect of a Probiotic Combination in an Experimental Mouse Model and Clinical Patients With Chronic Kidney Disease: A Pilot Study. Front Nutr 2021;8:661794. [PMID: 34136518 DOI: 10.3389/fnut.2021.661794] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Aw W, Fukuda S. Toward the comprehensive understanding of the gut ecosystem via metabolomics-based integrated omics approach. Semin Immunopathol 2015;37:5-16. [PMID: 25338280 DOI: 10.1007/s00281-014-0456-2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 3.8] [Reference Citation Analysis]
34 Kubotera N, Prokopienko AJ, Garba AO, Pai AB. Endotoxin binding by sevelamer: potential impact on nutritional status. Int J Nephrol 2013;2013:954956. [PMID: 23401772 DOI: 10.1155/2013/954956] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
35 Mcintyre CW. Cardiovascular benefits of daily haemodialysis: peeling the onion. Nephrology Dialysis Transplantation 2014;29:1-4. [DOI: 10.1093/ndt/gft315] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
36 Jiang S, Xie S, Lv D, Wang P, He H, Zhang T, Zhou Y, Lin Q, Zhou H, Jiang J, Nie J, Hou F, Chen Y. Alteration of the gut microbiota in Chinese population with chronic kidney disease. Sci Rep 2017;7:2870. [PMID: 28588309 DOI: 10.1038/s41598-017-02989-2] [Cited by in Crossref: 69] [Cited by in F6Publishing: 75] [Article Influence: 13.8] [Reference Citation Analysis]
37 Zhang P, Fang J, Li G, Zhang L, Lai X, Xu L, Liu L, Xiong Y, Li L, Zhang T, Wan J, Xu H, Chen R, Zhang W, Ma J, Chen Z. Sex Differences in Fecal Microbiota Correlation With Physiological and Biochemical Indices Associated With End-Stage Renal Disease Caused by Immunoglobulin a Nephropathy or Diabetes. Front Microbiol 2021;12:752393. [PMID: 34899638 DOI: 10.3389/fmicb.2021.752393] [Reference Citation Analysis]
38 Anders HJ, Andersen K, Stecher B. The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease. Kidney Int. 2013;83:1010-1016. [PMID: 23325079 DOI: 10.1038/ki.2012.440] [Cited by in Crossref: 239] [Cited by in F6Publishing: 209] [Article Influence: 26.6] [Reference Citation Analysis]
39 Clauser M, Altenberger J. Adipositas und kardiale Kachexie bei chronischer Herzinsuffizienz. Herz 2013;38:610-7. [DOI: 10.1007/s00059-013-3885-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
40 Zhang YJ, Li S, Gan RY, Zhou T, Xu DP, Li HB. Impacts of gut bacteria on human health and diseases. Int J Mol Sci. 2015;16:7493-7519. [PMID: 25849657 DOI: 10.3390/ijms16047493] [Cited by in Crossref: 325] [Cited by in F6Publishing: 274] [Article Influence: 46.4] [Reference Citation Analysis]
41 McIntyre CW, Harrison LE, Eldehni MT, Jefferies HJ, Szeto CC, John SG, Sigrist MK, Burton JO, Hothi D, Korsheed S. Circulating endotoxemia: a novel factor in systemic inflammation and cardiovascular disease in chronic kidney disease. Clin J Am Soc Nephrol. 2011;6:133-141. [PMID: 20876680 DOI: 10.2215/cjn.04610510] [Cited by in Crossref: 276] [Cited by in F6Publishing: 146] [Article Influence: 23.0] [Reference Citation Analysis]
42 Handelman GJ, Levin NW. Iron and anemia in human biology: a review of mechanisms. Heart Fail Rev 2008;13:393-404. [PMID: 18363095 DOI: 10.1007/s10741-008-9086-x] [Cited by in Crossref: 78] [Cited by in F6Publishing: 60] [Article Influence: 5.6] [Reference Citation Analysis]
43 Ficek J, Wyskida K, Ficek R, Wajda J, Klein D, Witkowicz J, Rotkegel S, Spiechowicz-Zatoń U, Kocemba-Dyczek J, Ciepał J, Więcek A, Olszanecka-Glinianowicz M, Chudek J. Relationship between plasma levels of zonulin, bacterial lipopolysaccharides, D-lactate and markers of inflammation in haemodialysis patients. Int Urol Nephrol 2017;49:717-25. [PMID: 28044237 DOI: 10.1007/s11255-016-1495-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
44 Perianayagam MC, Jaber BL. Endotoxin-binding affinity of sevelamer hydrochloride. Am J Nephrol 2008;28:802-7. [PMID: 18506105 DOI: 10.1159/000135691] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
45 Evenepoel P, Dejongh S, Verbeke K, Meijers B. The Role of Gut Dysbiosis in the Bone-Vascular Axis in Chronic Kidney Disease. Toxins (Basel) 2020;12:E285. [PMID: 32365480 DOI: 10.3390/toxins12050285] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
46 Ma C, Bi K, Zhang M, Su D, Fan X, Ji W, Wang C, Chen X. Toxicology effects of morning glory seed in rat: a metabonomic method for profiling of urine metabolic changes. J Ethnopharmacol 2010;130:134-42. [PMID: 20435118 DOI: 10.1016/j.jep.2010.04.031] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 3.0] [Reference Citation Analysis]
47 Viramontes-hörner D, Márquez-sandoval F, Martín-del-campo F, Vizmanos-lamotte B, Sandoval-rodríguez A, Armendáriz-borunda J, García-bejarano H, Renoirte-lópez K, García-garcía G. Effect of a Symbiotic Gel (Lactobacillus acidophilus + Bifidobacterium lactis + Inulin) on Presence and Severity of Gastrointestinal Symptoms in Hemodialysis Patients. Journal of Renal Nutrition 2015;25:284-91. [DOI: 10.1053/j.jrn.2014.09.008] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 4.7] [Reference Citation Analysis]